$2.29
-0.15-5.94%
Ult. Agg.: Oct 23, 10:45 AM
Protara Therapeutics (TARA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.32 | $-0.37 | $-0.32 | $-0.40 |
| Actual | $-0.36 | $-0.31 | $-0.37 | $-0.31 |
| Surprise | -12.5% | +16.2% | -15.6% | +22.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.38 | $-0.42 | $-0.44 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.36 | $-0.32 | -12.5 % |
| Q1 | May 13, 2026 | $-0.31 | $-0.37 | 16.2 % |
| Q4 | Mar 10, 2026 | $-0.37 | $-0.32 | -15.6 % |
| Q3 | Nov 10, 2025 | $-0.31 | $-0.40 | 22.5 % |